Abstract:Mitochondrial dynamics and function are important for cell survival regulation under stress. In this study, we report that cerebral ischemia/reperfusion (I/R) injury significantly reduced mitochondrial function through reduced PTEN‐induced kinase 1 (PINK1) expression, ATP (Adenosine triphosphate) levels, and increased oxidative stress compared to sham rats. PINK1 overexpression mice significantly improved mitochondrial function by increased mitochondrial complex I, II, and III activities and ATP levels with co… Show more
“…The mechanism(s) involved in mitophagy regulation include PINK1/Parkin-and mitophagy receptors-dependent pathway (Eiyama and Okamoto, 2015). The study showed that PINK1/Parkin acts cooperatively in adjusting mitochondrial balancing function and marking impaired mitochondria (Fan et al, 2019;Wen et al, 2020). Notably, ubiquitylation and deubiquitylation play roles in modulating significantly (Tanaka, 2020).…”
Berberine has been verified to protect cardiac function in patients with heart failure (HF). However, the mechanism(s) involved in berberine-mediated cardioprotective effects has not been clearly elucidated. The aim of this study was to further investigate the mechanism(s) involved in the beneficial effects of berberine on transverse aortic contraction (TAC)-induced chronic HF. Mice were randomly divided into four groups. Berberine was administered at a dose of 50 mg/kg/day for 4 weeks via oral gavage. Our findings showed that TAC-induced pressure overload (PO) prompted cardiac dysfunction, cardiac hypertrophy, interstitial fibrosis, cardiomyocyte apoptosis and mitochondrial injury, accompanied with suppressed mitophagy, the effects of which were attenuated by berberine. Furthermore, mitophagy regulators PINK1 and mito-Parkin were downregulated in TAC-induced HF, while berberine upregulated PINK1/Parkinmediated mitophagy. Notably, knockdown of PINK1 by small interfering RNA significantly suppressed Parkin-mediated mitochondrial ubiquitination and nullified the beneficial actions on HF exerted by berberine. Taken together, our results indicated that berberine plays a critical role in attenuating cardiac hypertrophy and preserving cardiac function from PO induced HF. The potential underlying mechanism is the activation of mitochondrial autophagy via PINK1/Parkin/Ubiquitination pathway.
“…The mechanism(s) involved in mitophagy regulation include PINK1/Parkin-and mitophagy receptors-dependent pathway (Eiyama and Okamoto, 2015). The study showed that PINK1/Parkin acts cooperatively in adjusting mitochondrial balancing function and marking impaired mitochondria (Fan et al, 2019;Wen et al, 2020). Notably, ubiquitylation and deubiquitylation play roles in modulating significantly (Tanaka, 2020).…”
Berberine has been verified to protect cardiac function in patients with heart failure (HF). However, the mechanism(s) involved in berberine-mediated cardioprotective effects has not been clearly elucidated. The aim of this study was to further investigate the mechanism(s) involved in the beneficial effects of berberine on transverse aortic contraction (TAC)-induced chronic HF. Mice were randomly divided into four groups. Berberine was administered at a dose of 50 mg/kg/day for 4 weeks via oral gavage. Our findings showed that TAC-induced pressure overload (PO) prompted cardiac dysfunction, cardiac hypertrophy, interstitial fibrosis, cardiomyocyte apoptosis and mitochondrial injury, accompanied with suppressed mitophagy, the effects of which were attenuated by berberine. Furthermore, mitophagy regulators PINK1 and mito-Parkin were downregulated in TAC-induced HF, while berberine upregulated PINK1/Parkinmediated mitophagy. Notably, knockdown of PINK1 by small interfering RNA significantly suppressed Parkin-mediated mitochondrial ubiquitination and nullified the beneficial actions on HF exerted by berberine. Taken together, our results indicated that berberine plays a critical role in attenuating cardiac hypertrophy and preserving cardiac function from PO induced HF. The potential underlying mechanism is the activation of mitochondrial autophagy via PINK1/Parkin/Ubiquitination pathway.
“…PINK1 and Parkin are two proteins stably expressed in the nervous system of human being [ 39 , 40 ], and crucial for neuronal survival functioning as multipurpose proteins in a variety of toxic insults [ 41 , 42 ]. Notably, PINK1/Parkin pathway has been arisen extensive attention in exploring the interplay between hypoxia-related mitophagy and cerebral ischemia [ 8 , 19 , 22 ]. As a sensor of mitochondrial damage, PINK1 accumulates in the OMM and recruits cytosolic Parkin to damaged mitochondria.…”
Section: Discussionmentioning
confidence: 99%
“…Then Parkin stimulates the degradation of mitochondria by ubiquitination of mitochondrial proteins [ 43 ]. Cerebral ischemia would alter PINK1 and Parkin expression [ 19 , 22 ]. Demyanenko et al demonstrated that expression of Parkin and PINK1 were increased in the cortical penumbra at 1 h after photothrombotic infarction in Wistar rats [ 44 ].…”
Section: Discussionmentioning
confidence: 99%
“…However, HPC-promoted PINK1 and Parkin translocation to mitochondria, accompanied by the increased mitochondrial ubiquitination and subsequent mitochondrial clearance after tGCI. Moreover, PINK1/Parkin-induced mitophagy is protective for the hippocampus in vivo and in vitro against cerebral ischemia [ 20 , 21 ], which mainly arises from the suppression of oxidative stress, alleviation of neuronal apoptosis [ 48 ], and improvement of mitochondrial function [ 22 ]. Consistently, we found that PINK1 silencing abrogated the activation of PINK1/Parkin pathway, inhibited the degradation of damaged mitochondria, and finally eliminated the neuroprotection induced by HPC after tGCI.…”
Section: Discussionmentioning
confidence: 99%
“…Wang et al demonstrated that the activation of PINK1/Parkin pathway effectively ameliorates neuronal damage in the cortex and hippocampal CA1 region via mediating damaged mitochondrial clearance after MCAO [ 21 ]. Furthermore, PINK1/Parkin pathway plays a vital role in the interplay between hypoxia-related mitophagy and cerebral ischemia [ 19 , 22 ]. Nevertheless, little is understood whether HPC promotes mitochondrial ubiquitination via activating PINK1/Parkin pathway, thus inducing mitophagy to attenuate neuronal injury after tGCI.…”
Mitophagy alleviates neuronal damage after cerebral ischemia by selectively removing dysfunctional mitochondria. Phosphatase and tensin homolog (PTEN) induced putative kinase 1 (PINK1)/Parkin-mediated mitophagy is the most well-known type of mitophagy. However, little is known about the role of PINK1/Parkin-mediated mitophagy in ischemic tolerance induced by hypoxic postconditioning (HPC) with 8% O2 against transient global cerebral ischemia (tGCI). Hence, we aimed to test the hypothesis that HPC-mediated PINK1/Parkin-induced mitochondrial ubiquitination and promotes mitophagy, thus exerting neuroprotection in the hippocampal CA1 subregion against tGCI. We found that mitochondrial clearance was disturbed at the late phase of reperfusion after tGCI, which was reversed by HPC, as evidenced by the reduction of the translocase of outer mitochondrial membrane 20 homologs (TOMM20), translocase of inner mitochondrial membrane 23 (TIMM23) and heat shock protein 60 (HSP60) in CA1 after HPC. In addition, HPC further increased the ratio of LC3II/I in mitochondrial fraction and promoted the formation of mitophagosomes in CA1 neurons after tGCI. The administration of lysosome inhibitor chloroquine (CQ) intraperitoneally or mitophagy inhibitor (Mdivi-1) intracerebroventricularly abrogated HPC-induced mitochondrial turnover and neuroprotection in CA1 after tGCI. We also found that HPC activated PINK1/Parkin pathway after tGCI, as shown by the augment of mitochondrial PINK1 and Parkin and the promotion of mitochondrial ubiquitination in CA1. In addition, PINK1 or Parkin knockdown with small-interfering RNA (siRNA) suppressed the activation of PINK1/Parkin pathway and hampered mitochondrial clearance and attenuated neuroprotection induced by HPC, whereas PINK1 overexpression promoted PINK1/Parkin-mediated mitophagy and ameliorated neuronal damage in CA1 after tGCI. Taken together, the new finding in this study is that HPC-induced neuroprotection against tGCI through promoting mitophagy mediated by PINK1/Parkin-dependent pathway.
Cerebral ischemia/reperfusion (I/R) injury remains a grievous health threat, and herein effective therapy is urgently needed. This study explored the protection of neuroglobin (Ngb) in rats with cerebral I/R injury. The focal cerebral I/R rat models were established by middle cerebral artery occlusion (MCAO) and neuronal injury models were established by oxygen–glucose deprivation/reoxygenation (OGD/R) treatment. The brain injury of rats was assessed. Levels of Ngb, Bcl‐2, Bax, endoplasmic reticulum stress (ERS)‐related markers, and Syt1 were measured by immunofluorescence staining and Western blotting. The cytotoxicity in neurons was assessed by lactate dehydrogenase (LDH) release assay. Levels of intracellular Ca2+ and mitochondrial function‐related indicators were determined. The binding between Ngb and Syt1 was detected by co‐immunoprecipitation. Ngb was upregulated in cerebral I/R rats and its overexpression alleviated brain injury. In OGD/R‐induced neurons, Ngb overexpression decreased LDH level and neuronal apoptosis, decreased Ca2+ content, and mitigated mitochondrial dysfunction and ERS‐related apoptosis. However, Ngb silencing imposed the opposite effects. Importantly, Ngb could bind to Syt1. Syt1 knockdown partially counteracted the alleviation of Ngb on OGD/R‐induced injury in neurons and cerebral I/R injury in rats. Briefly, Ngb extenuated cerebral I/R injury by repressing mitochondrial dysfunction and endoplasmic reticulum stress‐mediated neuronal apoptosis through Syt1.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.